Roundhill GLP-1与减肥主动型ETF OZEM 深 沪
已收盘 09-11 16:00:00 美东时间
31.1335
-0.320
-1.02%
华盛通- 最 高31.438
- 今 开31.38
- 成交量 8738股
- 最 低 31.1335
- 昨 收 31.4534
- 总市值 5821.96万
- 52周最高 37.15
- 市盈率 静 --
- 换手率 0.47%
- 52周最低 25.9301
- 委 比 -98.51%
- 总股本 187.00万
- 历史最高 37.15
- 量 比 0.28
- 振 幅 0.97%
- 历史最低 19.6001
- 每 手 1
- 风险率 2.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多GLP-1 trials show mood improvement rather than the ‘Ozempic personality’ – Dr. Angela Fitch
Data from randomized controlled trials shows that most patients’ moods actually improve when treated for obesity with GLP-1 medications, according to Dr. Angela Fitch, Knownwell chief medical officer ...
04-17 22:13
Here are the quant ratings of OZEM’s top holdings amid Novo's selloff
The Roundhill GLP-1 & Weight Loss ETF (OZEM) came into focus on Monday after Novo Nordisk (NVO) shares tumbled as the firm's next-generation obesity drug CagriSema delivered less weight loss than Eli ...
02-24 02:06
OZEM stock: What the Ratings say
The Roundhill GLP-1 & Weight Loss ETF (OZEM) came into focus on Monday after Novo Nordisk (NVO) shares tumbled as the firm's next-generation obesity drug CagriSema delivered less weight loss than Eli ...
02-23 23:38
EXCLUSIVE: Trump 'Amplified' Several Investing Themes – ETF CEO Picks 3 Sectors Benefitting The Most
President Donald Trump may be creating investment opportunities in themes and helping put an emphasize thematic ETFs.
01-28 06:05
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk
Novo's trial setback tests GLP-1-heavy ETFs, highlighting concentration risks while Eli Lilly's diversified pipeline offers relative resilience.
2025-11-25 01:06
华盛早报 | 外资又来唱多！大摩称中国股市有望继续上涨；美联储12月降息概率再降至43%
外资又来唱多！大摩称中国股市有望继续上涨；美联储12月降息概率一降再降，现已接近40%；拼多多、小米集团今日发财报>>
2025-11-18 08:23
